New Formulations: Glatiramer Acetate
October 2004
in “
Australian Prescriber
”
Studysummary This abstract reviews the management of polycystic ovary syndrome and highlights the potential benefits of lifestyle changes over metformin in reducing type 2 diabetes risk, yet reports no new clinical outcomes.
Our plain-language summary. Not medical advice or a treatment recommendation. Consult a qualified healthcare professional before changing treatment. Full disclaimer
The document discussed the management of hirsutism and the long-term risks associated with insulin resistance, particularly in the context of polycystic ovary syndrome (PCOS). It noted that while medications like flutamide and finasteride were not widely used in Australia due to potential side effects, such as hepatotoxicity and teratogenicity, lifestyle changes were emphasized as a more effective approach. The Diabetes Prevention Program Research Group's findings suggested that lifestyle modifications were more successful than metformin in reducing the incidence of type 2 diabetes, highlighting the importance of reducing body mass and improving insulin sensitivity to mitigate cardiovascular risks.
